Oklo公司最近与人工智能解决方案提供商和数据中心运营商Switch达成协议，未来将为其提供高达12千兆瓦的能源支持。这一发展不仅为Oklo的商业前景打下基础，也让人对其能否在核能市场中占据一席之地充满期待。

智通财经APP获悉，英伟达(NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展(CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。Wedbush分析师Dan ...

另一方面，Salesforce作为全球领先的客户关系管理（CRM）软件公司，也在积极推进AI战略。近期，Salesforce推出了以“Einstein ...

Wedbush downgraded Keros Therapeutics (KROS) to Neutral from Outperform with a price target of $15, down from $47. The firm has removed cibotercept for pulmonary arterial hypertension from the ...

英伟达 (NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展 (CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。

Wedbush currently has a “Outperform” rating and a $34.00 target price on the stock. The consensus estimate for Kiniksa Pharmaceuticals’ current full-year earnings is ($0.55) per share.

Wedbush Securities周四开始追踪Oklo—— OpenAI负责人Sam Altman支持的核电初创公司 —— 并给予其“跑赢大盘”的评级。而前一天，该公司宣布与人工智能 ...

Dan Ives, Wedbush Securities global head of tech research, joins CNBC's 'The Exchange' to discuss the looming TikTok ban in ...

KB Home (NYSE:KBH – Free Report) – Investment analysts at Wedbush reduced their FY2025 earnings per share estimates for shares of KB Home in a note issued to investors on Monday, January 13th.

In a report released today, Jay McCanless from Wedbush reiterated a Hold rating on DR Horton (DHI – Research Report), with a price target of $180.00. The company’s shares closed yesterday at ...

Netflix is set to report fourth-quarter results after the closing bell on Tuesday, with Wall Street analysts holding mostly ...

The popular platform could be banned on Jan. 19 under a federal law, while many parties have expressed interest in buying the ...